KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Other Non Operating Income (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Other Non Operating Income for 5 consecutive years, with $718000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 84.72% to $718000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 133.02% year-over-year, with the annual reading at $718000.0 for FY2025, 134.57% up from the prior year.
  • Other Non Operating Income hit $718000.0 in Q4 2025 for GoodRx Holdings, up from $694000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4.7 million in Q4 2024 to a low of -$4.0 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged -$296833.3 across 3 years, with a median of -$557000.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: surged 217.27% in 2024 and later crashed 84.72% in 2025.
  • Year by year, Other Non Operating Income stood at -$4.0 million in 2023, then soared by 217.27% to $4.7 million in 2024, then plummeted by 84.72% to $718000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for GDRX at $718000.0 in Q4 2025, $694000.0 in Q2 2025, and $4.7 million in Q4 2024.